Mild Cognitive Impairment Clinical Trial
— TRAIN-MCIOfficial title:
Cognitive Training in Mild Cognitive Impairment: Effects on Sleep, Cognition and Arousal
NCT number | NCT04899089 |
Other study ID # | 2053302 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 28, 2021 |
Est. completion date | June 1, 2023 |
Verified date | October 2023 |
Source | University of Missouri-Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Older adults (60+ years of age) who meet criteria for mild cognitive impairment and insomnia will be randomly assigned to cognitive training or trivia training and will complete measures of anxiety, sleep, cognition (objective, self-efficacy), and arousal at baseline, and post-intervention. For cognitive training, participants will be provided with login information to access the computerized training, and will complete 8 weeks (45 mins 3x/week) of cognitive training. For trivia training, participants will receive weekly emails that contain trivia assignments that they will complete for 8 weeks (45 mins 3x/week). We will evaluate short-term (i.e., post-training) effects of the two training conditions on subjective anxiety, sleep, arousal, and subjective and objective cognition.
Status | Completed |
Enrollment | 48 |
Est. completion date | June 1, 2023 |
Est. primary completion date | June 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility | Inclusion Criteria: 1. 60+ yrs of age 2. meet criteria for mild cognitive impairment 3. no neurological or psychiatric illness or dementia 4. non-gamers (<2 hour of video/brain training games/week over last 2 yrs) 5. proficient in English (reading and writing) 6. meet clinical dx criteria for Insomnia (e.g., insomnia complaints for 6+ months, complaints occur despite adequate opportunity and circumstances for sleep, consist of one of the following: difficulty falling asleep, staying asleep, or waking up too early, and daytime dysfunction due to insomnia) Exclusion Criteria: 1. unable to provide informed consent 2. unable to undergo randomization 3. other sleep disorder (e.g., sleep apnea, restless legs syndrome) 4. severe untreated psychiatric comorbidity 5. psychotropic or other medications that alter sleep (unless stabilized for 6 months) 6. uncorrected visual/auditory impairments 7. participation in nonpharmacological tx for sleep/fatigue/mood/cognition outside the current study |
Country | Name | City | State |
---|---|---|---|
United States | University of Missouri | Columbia | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Missouri-Columbia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Objective Cognition - Computerized Cognitive Tasks | Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed, attention, memory). | Up to 10 weeks | |
Primary | Subjective Cognitive Self-Efficacy. - Cognitive Failures Questionnaire | A 25 item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy. | Up to 10 weeks | |
Primary | Subjective Behavioral Sleep- Electronic Daily Sleep Diaries | Electronic Daily Sleep Diaries. Online diaries completed each morning (~5 mins) during the study. Diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality. | Up to 10 days | |
Primary | Subjective Behavioral Sleep- Insomnia Severity Index | Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment. Commonly used in insomnia treatment outcome research. | Up to 10 weeks | |
Primary | Objective Sleep-Watchpat | Single night objective sleep recording via a wrist worn device. | Up to 10 weeks | |
Secondary | Physiological Arousal- Heart Rate Variability | CorSense monitor assessed 5 min heart rate recordings both at rest. Time index variables: SDNN (standard deviation of normal to normal heartbeat intervals) | Impact of game related experience will be measured at baseline | |
Secondary | Anxiety - State-Trait Anxiety Inventory | Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment. | Up to 10 weeks | |
Secondary | Game-related experience- Sessions and duration played | During the intervention phase the cognitive training group will play games and will need to log the days and duration played. | Up to 10 weeks | |
Secondary | Circadian Rhythm- Morningness-Eveningness Questionnaire | 19-item questionnaire that assesses preference for morning, afternoon, and evening activities. Total score reflects degree of "morningness" or "eveningness" type. | Up to 10 weeks | |
Secondary | Perceived Stress- Perceived Stress Scale Subjective Arousal- Perceived Stress Scale | Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful. The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a scale from 0 (never) to 4 (very often) how often they felt or thought a specific way. Higher scores correspond to higher perceived stress. | Up to 10 weeks | |
Secondary | Subjective Arousal- Arousal Predisposition Scale | Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal. Higher scores indicate greater predisposition to arousal. | Up to 10 weeks | |
Secondary | Game Engagement Questionnaire | Questionnaire assessing the experience of the game. | Up to 10 weeks | |
Secondary | Mood-Depression-Beck Depression Inventory-II | 21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms. | Up to 10 weeks | |
Secondary | Alcohol Use - Alcohol Use Disorder Test | 10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year. | Baseline | |
Secondary | Physical Activity - International Physical Activity Questionnaire | 7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life. | Up to 10 weeks | |
Secondary | Personality - Big Five Inventory | 10 question assessment measuring personality | Baseline | |
Secondary | Computer Proficiency- Computer Proficiency Questionnaire | This questionnaire asks about participants' ability to perform a number of tasks with a computer. Will be examined as a covariate. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |